Editorial: The contribution of genetic studies in shifting the immunopathogenesis paradigm of Crohn's disease

Expert Review of Clinical Immunology

Volumn 5, Issue 4, 2009, Pages 361-364

  Villani, Alexandra Chloé ^a,b   Franchimont, Denis ^a,c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

BIOLOGICAL THERAPY; CHRONIC DISEASE; CROHN DISEASE; DISEASE PREDISPOSITION; DRUG TARGETING; EDITORIAL; ENTERITIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; GENOME WIDE ASSOCIATION STUDIES; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FLORA; MUCOSAL IMMUNITY;

EID: 77649148700     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.21     Document Type: Editorial

References (31)

1. Marchesi J, Shanahan F. The normal intestinal microbiota. Curr. Opin. Infect. Dis. 20, 508-513 (2007).
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
4. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
5. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 8, 458-466 (2008).
6. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
7. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
8. Villani AC, Lemire M, Fortin G et al. Common variants in the NLRP3 region contribute to Crohn disease susceptibility. Nat. Genet. 41, 71-76 (2009).
9. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
10. Yamazaki K, McGovern D, Ragoussis J et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 14, 3499-3506 (2005).
11. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1403-1405 (2006).
12. Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007). (Pubitemid 46184351)
13. Parkes M, Barrett JC, Prescott NJ et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39, 1045-1051 (2007).
14. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
15. Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007).
16. Libioulle C, Louis E, Hansoul S et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, 538-543 (2007).
17. Franke A, Hampe J, Rosenstiel P et al. Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS ONE 2, e691 (2007).
18. Raelson JV, Little RD, Ruether A et al. Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc. Natl Acad. Sci. USA 104, 14747-14752 (2007).
19. Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
20. Schmid D, Dengjel J, Schoor O, Stevanovic S, Münz C. Autophagy in innate and adaptive immunity against intracellular pathogens. J. Mol. Med. 84, 194-202 (2006).
21. Fisher SA, Tremelling M, Anderson CA et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat. Genet. 40, 710-712 (2008).
22. Franke A, Balschun T, Karlsen TH et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat. Genet. 40, 713-715 (2008).
23. Kozuch PL, Hanauer SB. Treatment of inflammatory bowel disease: a review of medical therapy. World J. Gastroenterol. 14, 354-377 (2008).
24. Fedorak RN, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2008. J. Clin. Gastroenterol. 42, S97-S103 (2008).
25. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst. Rev. 4, CD004826 (2006).
26. Rahimi R, Nikfar S, Rahimi F et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig. Dis. Sci. 53, 2524-2531 (2008).
27. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig. Dis. Sci. 45, 1462-1464 (2000).
28. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51, 405-409 (2002).
29. Bousvaros A, Guandalini S, Baldassano RN et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm. Bowel Dis. 11, 833-839 (2005).
30. Marteau P, Lemann M, Seksik P et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double-blind, placebocontrolled GETAID trial. Gut 55, 842-847 (2006).
31. Van Gossum A, Dewit O, Louis E et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo caecal resection. Inflamm. Bowel Dis. 13, 135-142 (2007)